-- 根據路透社週一報道，印尼正與日本汽車巨頭豐田汽車公司（TM）就潛在的生物乙醇生產合作項目進行磋商。 印尼投資部副部長托多圖阿·帕薩里布表示，該項目涉及印尼國有企業Pertamina的可再生能源部門，工廠選址在蘇門答臘島南端的楠榜省。 該廠計畫年產6萬千升生物乙醇，如果雙方達成協議，最快可能在2026年下半年動工建設，並於2028年開始投產。 帕薩里布表示，工廠的原料將來自新建的6,000公頃（約14,800英畝）高粱種植園，並估計總投資額可能達到2億至3億美元。 日本下一代汽車燃料生物質創新研究協會（raBit）也參與了相關討論。同時，豐田高層強調，該工廠生產的生物乙醇可用於該公司自有車輛的燃料。 同時，印尼正大力推動利用棕櫚生物質、玉米和高粱等國內原料擴大生物乙醇產量，旨在減少對進口燃料的依賴。印尼政府也計劃從2028年起強制規定汽油中摻入10%的生物乙醇。 豐田和印尼投資部均未立即回覆的置評請求。 （市場動態新聞來自與全球市場專業人士的對話。我們認為這些資訊來自可靠來源，但可能包含傳聞和推測。準確性無法保證。）
Related Articles
Asia
Hong Kong Stocks Edge Lower as U.S.-Iran Talks Stall; CITIC Securities Gains on Profit Jump
Hong Kong stocks ended little changed Monday as U.S.-Iran talks stalled, heightening concerns over potential disruptions to energy flows.The Hang Seng Index fell 52.42 points to end marginally lower at 25,925.65, while the Hang Seng China Enterprises Index dropped 19.30 points to 8,756.32.U.S. President Donald Trump scrapped plans to send envoys to Islamabad for weekend talks, signaling a pause in diplomatic efforts.He said Sunday Iran could call if it wants to negotiate an end to the conflict, while insisting it must not possess nuclear weapons, after Tehran urged the removal of obstacles to a deal, including the U.S. blockade of its ports.Sentiment was partially supported after an Axios report said Iran may prioritize reopening the strait while postponing nuclear negotiations.Meanwhile, China's industrial profits accelerated in March, marking their fastest growth in six months.Profits rose 15.8% year on year, up from a 15.2% increase in the January-February period, according to data from the National Bureau of Statistics released Monday.In corporate news, CITIC Securities (HKG:6030, SHA:600030) closed nearly 2% higher after reporting a 55% growth in first-quarter profit.
$^HSI$HKG:6030$SHA:600030
Asia
WuXi AppTec's Q1 Profit Up 27%
WuXi AppTec (HKG:2359) booked 4.65 billion yuan in attributable profit for the first quarter of 2026, up 27% from 3.67 billion yuan a year earlier, according to a Hong Kong bourse filing Monday.Earnings per share were 1.58 yuan, compared with 1.28 yuan in the prior year.Revenue jumped 29% year on year to 12.44 billion yuan, figures showed.
$HKG:2359
Asia
Care Health Insurance CEO Steps Down
Religare Enterprises (NSE:RELIGARE, BOM:532915) said the managing director and chief executive officer of its subsidiary, Care Health Insurance, has stepped down from the role on April 25 upon completion of tenure, according to an Indian bourse filing on Sunday.Shares of the company rose nearly 2% in Monday's trade.
$BOM:532915$NSE:RELIGARE